menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

The unanswered questions in the NHS’s new cancer plan

10 0
04.02.2026

NHS England’s new national cancer plan focuses on catching cancer earlier and treating it faster. The government has also promised to meet all cancer waiting-time targets by 2029. This includes a long-missed target, namely that most patients should start treatment within 62 days of being referred by their GP.

Cancer survival in England has improved, but it still trails behind countries such as Australia, Canada and Nordic nations for many common cancers.

For some of the deadliest cancers – lung, liver, oesophageal, pancreatic and stomach cancers – the UK ranks near the bottom of the league table among similar wealthy countries. Fewer patients are still alive five years after diagnosis compared to other nations.

No single cause explains this gap. A key factor is that people in the UK are more likely to be diagnosed when their cancer is already advanced. This makes it harder to cure and limits treatment options.

Getting to see a specialist can also be slow. Patients struggle to get GP appointments, symptoms may not seem urgent at first, and people often need multiple visits before getting referred to a specialist.

Once in the system, patients hit more delays. The NHS has fewer CT and MRI scanners per person than many comparable health systems, contributing to waits for imaging and other tests.

There are also longstanding workforce shortages, especially in radiology and oncology. This means fewer specialists to read scans, plan treatment and deliver radiotherapy and chemotherapy. Limited surgical capacity, operating theatre time and radiotherapy machines cause further delay treatment.

How countries record cancer survival accounts for some of the difference. But even when researchers adjust for this, the UK still lags behind the best-performing countries. The result is a system where many individual steps function under strain, and those small delays add up for patients.

The 62-day target measures the journey from urgent referral for suspected cancer to starting treatment. In principle, a person referred urgently by their GP, a screening programme or a hospital doctor should have their diagnosis confirmed and their initial treatment underway within just over two months.

That sounds straightforward. But for patients, it’s a complex and emotionally draining experience.

The journey usually starts when someone notices a worrying symptom – a breast lump, unusual bleeding, a persistent cough or a change in their bowels – and gets a GP appointment. If the GP is concerned, they make an urgent referral to a specialist clinic. The patient then waits for their first hospital appointment, where they’ll have further assessment and tests: blood tests, X-rays, endoscopy, CT scans, MRI........

© The Conversation